Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

VIVUS Inc (NASDAQ:VVUS)

1.16
Delayed Data
As of 3:59pm ET
 +0.03 / +2.65%
Today’s Change
0.93
Today|||52-Week Range
1.47
+0.87%
Year-to-Date
Shire (SHPG) Receives MAA Validation for Veyvondi by EMA
11:43am / Zacks.com - Paid Partner Content
BioMarin (BMRN) in Focus: Stock Moves 7% Higher
9:19am / Zacks.com - Paid Partner Content
Here's Why Geron (GERN) is a Good Stock to Invest in Now
11:21am / Zacks.com - Paid Partner Content
Myriad Genetics (MYGN) Catches Eye: Stock Moves Up 5.7%
8:52am / Zacks.com - Paid Partner Content
Indivor's Opioid Use Disorder Drug Meets Primary Endpoint
10:51am / Zacks.com - Paid Partner Content
Novartis Migraine Drug Accepted, AMD Positive in Phase III
Jun 21 / Zacks.com - Paid Partner Content
Glaxo's (GSK) Shingles Candidate Phase III Data Positive
10:51am / Zacks.com - Paid Partner Content
Shire's (SHPG) ADHD Drug Mydayis Receives Approval in US
Jun 21 / Zacks.com - Paid Partner Content
Novartis Announces Positive Results for Cardiovascular Drug
10:19am / Zacks.com - Paid Partner Content
Seattle Genetics (SGEN) Submits BLA to FDA for Cancer Drug
Jun 21 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close1.13
Today’s open1.13
Day’s range1.11 - 1.16
Volume1,318,245
Average volume (3 months)757,407
Market cap$119.4M
Dividend yield--
Data as of 3:59pm ET, 06/22/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-277.27%
Earnings growth (next 5 years)+0.84%
Revenue growth (last year)+30.21%
P/E ratio3.5
Price/Sales0.97
Price/Book6.52

Competitors

 Today’s
change
Today’s
% change
GEMPGemphire Therapeutic...-0.02-0.18%
--EcoGreen Internation...+0.00+1.17%
PRQRProQR Therapeutics N...+0.07+1.53%
ACRXAcelRx Pharmaceutica...-0.10-4.00%
Data as of 3:59pm ET, 06/22/2017

Financials

Next reporting dateAugust 8, 2017
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$124.3M
Annual profit (last year)$23.3M
Net profit margin18.75%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Director
Seth H. Z. Fischer
Chief Financial &
Accounting Officer
Mark K. Oki
Corporate headquarters
Campbell, California

Forecasts